Fratzl-Zelman Nadja, Roschger Paul, Kang Heeseog, Jha Smita, Roschger Andreas, Blouin Stéphane, Deng Zuoming, Cabral Wayne A, Ivovic Aleksandra, Katz James, Siegel Richard M, Klaushofer Klaus, Fratzl Peter, Bhattacharyya Timothy, Marini Joan C
Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK, and AUVA Trauma Center Meidling, 1st Medical Department Hanusch Hospital, Vienna, Austria.
Section on Heritable Disorders of Bone and Extracellular Matrix, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
J Bone Miner Res. 2019 May;34(5):883-895. doi: 10.1002/jbmr.3656. Epub 2019 Jan 22.
Melorheostosis is a rare non-hereditary condition characterized by dense hyperostotic lesions with radiographic "dripping candle wax" appearance. Somatic activating mutations in MAP2K1 have recently been identified as a cause of melorheostosis. However, little is known about the development, composition, structure, and mechanical properties of the bone lesions. We performed a multi-method phenotype characterization of material properties in affected and unaffected bone biopsy samples from six melorheostosis patients with MAP2K1 mutations. On standard histology, lesions show a zone with intensively remodeled osteonal-like structure and prominent osteoid accumulation, covered by a shell formed through bone apposition, consisting of compact multi-layered lamellae oriented parallel to the periosteal surface and devoid of osteoid. Compared with unaffected bone, melorheostotic bone has lower average mineralization density measured by quantitative backscattered electron imaging (CaMean: -4.5%, p = 0.04). The lamellar portion of the lesion is even less mineralized, possibly because the newly deposited material has younger tissue age. Affected bone has higher porosity by micro-CT, due to increased tissue vascularity and elevated 2D-microporosity (osteocyte lacunar porosity: +39%, p = 0.01) determined on quantitative backscattered electron images. Furthermore, nano-indentation modulus characterizing material hardness and stiffness was strictly dependent on tissue mineralization (correlation with typical calcium concentration, CaPeak: r = 0.8984, p = 0.0150, and r = 0.9788, p = 0.0007, respectively) in both affected and unaffected bone, indicating that the surgical hardness of melorheostotic lesions results from their lamellar structure. The results suggest a model for pathophysiology of melorheostosis caused by somatic activating mutations in MAP2K1, in which the genetically induced gradual deterioration of bone microarchitecture triggers a periosteal reaction, similar to the process found to occur after bone infection or local trauma, and leads to an overall cortical outgrowth. The micromechanical properties of the lesions reflect their structural heterogeneity and correlate with local variations in mineral content, tissue age, and remodeling rates, in the same way as normal bone. © 2018 American Society for Bone and Mineral Research.
骨肥大症是一种罕见的非遗传性疾病,其特征是致密的骨质增生性病变,在影像学上呈“滴蜡”外观。最近已确定MAP2K1基因的体细胞激活突变是骨肥大症的病因。然而,对于骨病变的发生发展、组成、结构及力学性能却知之甚少。我们对6例携带MAP2K1突变的骨肥大症患者的患骨和未患骨活检样本的材料特性进行了多方法表型特征分析。在标准组织学检查中,病变显示出一个区域,具有密集重塑的类骨单位样结构和明显的类骨质堆积,其表面覆盖着一层通过骨附着形成的壳,由与骨膜表面平行排列的致密多层板层组成,且无类骨质。与未患骨相比,通过定量背散射电子成像测量,骨肥大症的骨平均矿化密度较低(钙平均值:-4.5%,p = 0.04)。病变的板层部分矿化程度更低,可能是因为新沉积的物质组织年龄较轻。通过显微CT观察,患骨的孔隙率更高,这是由于组织血管增多以及在定量背散射电子图像上测定的二维微孔率升高(骨细胞陷窝孔隙率:+39%,p = 0.01)。此外,表征材料硬度和刚度的纳米压痕模量在患骨和未患骨中均严格依赖于组织矿化(与典型钙浓度的相关性,钙峰值:r = 0.8984,p = 0.0150,以及r = 0.9788,p = 0.0007),这表明骨肥大症病变的手术硬度源于其板层结构。结果提示了一种由MAP2K1基因的体细胞激活突变引起的骨肥大症病理生理学模型,其中基因诱导的骨微结构逐渐恶化引发骨膜反应,类似于骨感染或局部创伤后发生的过程,并导致整体皮质骨增生。病变的微观力学性能反映了其结构异质性,并与矿物质含量、组织年龄和重塑率的局部变化相关,与正常骨的情况相同。© 2018美国骨与矿物质研究学会。